MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Improvements of tremor control and life quality of refractory essential tremor patients after MR-guided focused ultrasound thalamotomy – A Taiwan experience

    H.C. Lai, K. Tsai, W.C. Chang, T. Taira, C.Y. Wei (Changhua County, Taiwan)

    Objective: To quantify the tremor control and life quality changes of refractory essential tremor (ET) patients after the MR-guided focused ultrasound (MRgFUS) thalamotomy in Taiwan.…
  • 2018 International Congress

    INTREPID: A Prospective, Double Blinded, Multicenter Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant Current Rechargeable System in Parkinson’s disease

    J. Vitek, R. Jain, L. Chen, I. Study Group, P. Starr (Minneapolis, MN, USA)

    Objective: INTREPID is designed to assess the improvement in motor function and quality of life in patients with Parkinson’s disease (PD) following Deep Brain Stimulation…
  • 2018 International Congress

    Specific active immunotherapy (SAIT) against alpha-synuclein with AFFITOPE® PD01A and PD03A: Results from the AFF009 phase I trial

    W. Meissner, A. Pavy-Le Traon, A. Foubert-Samier, M. Galitzky, B. Laurens, U. Sabatini, S. Schmidhuber, D. Winter, G. Galabova, G. Staffler, A. Schneeberger, A. Kutzelnigg, O. Rascol (Bordeaux Cedex, France)

    Objective: Phase I study with AFFITOPE® PD01A and PD03A to assess safety and tolerability as well as immunogenicity of this approach in MSA patients. Background:…
  • 2018 International Congress

    PASSPORT, An Ongoing Phase 2 Study in Patients with PSP– Baseline Characteristics

    T. Dam, A. Boxer, L. Golbe, G. Höglinger, H. Morris, I. Litvan, J.C. Corvol, A. Lang, C. Bechtold, I. Qureshi, M. Grundman, B. Han, J. O'Gorman, T. Olsson, S. Budd Haeberlein (Cambridge, MA, USA)

    Objective: To describe baseline characteristics of the participants with progressive supranuclear palsy (PSP) enrolled in the ongoing PASSPORT (NCT03068468) phase 2 study. Background: PSP is…
  • 2018 International Congress

    A German-Austrian multicenter, non-interventional, prospective study for the treatment with abobotulinumtoxinA injections in naïve and previously treated patients suffering from cervical dystonia

    W. Jost, A. Schramm, M. Müngersdorf, A. Stenner, P. Schwingenschuh, P. Maisonobe, M. Koch, B. Haslinger (Wolfach, Germany)

    Objective: In this prospective, multicenter, non-interventional study (NCT01840462) the primary objective was effectiveness of abobotulinumtoxinA in BoNT treatment-naïve and previously treated subjects after two injection…
  • 2018 International Congress

    Background: Transcranial magnetic stimulation (rTMS) may influence the progression of PD

    J. Málly (Sopron, Hungary)

    Objective: We hypothesized that the regularly repeated rTMS would decrease the development of PD and that there might be a synergistic effect with transcranial direct…
  • 2018 International Congress

    Effect of PD medication on disease progression as measured by rate of change in MDS_UPDRS and DaT SBR in PPMI study

    J. Cedarbaum, K. Evans, M. Yang, J. Xiao (Cambridge, MA, USA)

    Objective: In clinical trials for new PD therapies, it is common for patients to start to take approved symptomatic PD medications during the study. The…
  • 2018 International Congress

    Low-Fat Versus Ketogenic Diet In Parkinson’s Disease: A Pilot Randomized Controlled Trial

    M. Phillips, D. Murtagh, L. Gilbertson, F. Asztely, C. Lynch (Hamilton, New Zealand)

    Objective: To compare the plausibility, safety, and efficacy of a low-fat, high-carbohydrate diet versus a ketogenic diet in a hospital clinic of PD patients. Background:…
  • 2018 International Congress

    The PDSAFE falls prevention programe for people with Parkinson’s: A multicentre randomised controlled trial

    A. Ashburn, R. Pickering, L. Rochester, H. Roberts, C. Ballinger, S. Hulbert, I. Marian, C. Fitton, E. McIntosh, V. Goodwin, A. Nieuwboer, S. Lamb, K. Chivers Seymour (Southampton, United Kingdom)

    Objective: The aim was to examine the effectiveness of an exercise and strategy based intervention (PDSAFE) for fall reduction. Background: Evidence suggests exercise-based interventions might…
  • 2018 International Congress

    The effects of Nordic walking on gait functions in people with Parkinson’s disease: A long-term pilot study

    M. Mak, I. Wong-Yu (Hong Kong, Hong Kong)

    Objective: To examine the feasibility and the effects of a 4-week Nordic walking program on gait performance and aerobic endurance at treatment completion and 3-month…
  • « Previous Page
  • 1
  • …
  • 1195
  • 1196
  • 1197
  • 1198
  • 1199
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley